You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CHOLESTYRAMINE LIGHT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cholestyramine Light patents expire, and when can generic versions of Cholestyramine Light launch?

Cholestyramine Light is a drug marketed by Alkem Labs Ltd, Endo Operations, Epic Pharma Llc, Tagi, Teva, Teva Pharms, and Zydus Pharms. and is included in seven NDAs.

The generic ingredient in CHOLESTYRAMINE LIGHT is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cholestyramine Light

A generic version of CHOLESTYRAMINE LIGHT was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CHOLESTYRAMINE LIGHT?
  • What are the global sales for CHOLESTYRAMINE LIGHT?
  • What is Average Wholesale Price for CHOLESTYRAMINE LIGHT?
Summary for CHOLESTYRAMINE LIGHT
Drug patent expirations by year for CHOLESTYRAMINE LIGHT
Recent Clinical Trials for CHOLESTYRAMINE LIGHT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre Hospitalier Universitaire de NiceN/A
Loxo Oncology, Inc.Phase 1
Eli Lilly and CompanyPhase 1

See all CHOLESTYRAMINE LIGHT clinical trials

Pharmacology for CHOLESTYRAMINE LIGHT
Drug ClassBile Acid Sequestrant
Mechanism of ActionBile-acid Binding Activity

US Patents and Regulatory Information for CHOLESTYRAMINE LIGHT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 211799-001 Oct 19, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Tagi CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 209599-001 Nov 12, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 077203-002 Aug 26, 2005 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 074555-002 Sep 30, 1998 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Tagi CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 209599-002 Nov 12, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.